“
“Dosimetric properties of gamma-irradiated ZnAl2O4:Ce3+ (1-9 mol%) nanophosphors were studied and reported for the first time. The phosphor prepared by solution combustion check details route was well characterized by powder X-ray diffraction (PXRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) techniques. PXRD patterns of calcined phosphor show pure cubic phase of ZnAl2O4:Ce3+. Flake type morphology

was observed from SEM studies. The particle size estimated by Scherrer’s and Williamson Hall (W-H) plots and found to be in the range 11-17 nm. From photoluminescence (PL) studies two characteristic emission peaks at 363 and 480 nm were observed due to 5d-4f transitions of Ce3+ ions. The thermoluminescence (TL) glow curves of ZnAl2O4:Ce3+ (1-9 mol%) nanophosphor recorded two glow peaks 145 and 215 degrees C at a warming rate of 2.5 degrees C s(-1). The optimized TL intensity was observed for similar to 5 mol% Ce3+ concentration. The two TL glow peaks in the gamma-irradiated (0.1-6 kGy) ZnAl2O4:Ce3+ (5 mol%) nanophosphor indicates that two set of traps were activated within the temperature range 145 and 215 degrees C. The kinetic parameters (E,b,s) associated with the prominent glow peaks were estimated using

Chen’s glow peak shape method. The intensity of the TL glow Birinapant mw peak (145 degrees C) increases linearly with increase of gamma-dose upto 1 kGy above which it follows sub-linear behavior. Track interaction model (TIM) was used to explain the linearity/sub linearity/saturation behavior of TL intensity. The TL glow curves show simple glow peak structure, good reusability, low fading and wide range of linearity. Hence, the optimized ZnAl2O4:Ce3+ (5 mol%) nanophosphor was quite useful for radiation dosimetry and display applications. (C)

2013 Elsevier B.V. All rights reserved.”
“We tested agreement for small fibre morphology using corneal in vivo confocal microscopy between the recently available higher-magnification 300 mu m(2) and the conventional 400 mu m(2) field-of-view lenses. We found insignificant bias for corneal nerve fibre length indicating that either lens could reasonably be applied to research and clinical screening for diabetic neuropathy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.”
“The SET- and myeloid-Nervy-DEAF-1 (MYND)-domain MLN2238 manufacturer containing (Smyd) lysine methyltransferases 1-3 share relatively high sequence similarity but exhibit divergence in the substrate specificity. Here we report the crystal structure of the full-length human Smyd2 in complex with S-adenosyl-L-homocysteine (AdoHcy). Although the Smyd1-3 enzymes are similar in the overall structure, detailed comparisons demonstrate that they differ substantially in the potential substrate-binding site. The binding site of Smyd3 consists mainly of a deep and narrow pocket, while those of Smyd1 and Smyd2 consist of a comparable pocket and a long groove.